Efficacy of Sambucol on the Length of Time to Resolution of Influenza Illness
The trial will examine the efficacy of sambucol in the treatment of influenza. The primary efficacy endpoint will be the length of time to resolution of influenza illness.The double blind trial will be conducted at the Personnel Clinic, and at the Clinical virology Unit, Hadassah University Hospital, and will include 100 patients with laboratory-confirmed influenza infection, 50 in the sambucol and 50 in the placebo study arm.
100 Clinical Results associated with Razei Bar industries Ltd.
0 Patents (Medical) associated with Razei Bar industries Ltd.
100 Deals associated with Razei Bar industries Ltd.
100 Translational Medicine associated with Razei Bar industries Ltd.